Safety worries over copycat versions of Ozempic and Wegovy prompt state crackdowns

Indonesia Berita Berita

Safety worries over copycat versions of Ozempic and Wegovy prompt state crackdowns
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 57 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 86%

A growing number of states are threatening to take legal action against pharmacies that make or dispense unauthorized versions of Ozempic and Wegovy.

and West Virginia say they are aware that some compounding pharmacists are using a different form of semaglutide that is not approved by the FDA, raising safety concerns.

Joe Fontenot, executive director of the Louisiana Board of Pharmacy, told NBC News that the warnings do not mean compounding semaglutide is banned. That makes it nearly impossible for compounding pharmacies to make the drug because Novo Nordisk does not share the drug ingredients with compounding pharmacists, said Susan McCoy, executive director of the Mississippi Board of Pharmacy.Regulators are particularly concerned with medications that are made using semaglutide sodium salt, a cheaper and modified version of the compound that is used for scientific research but not intended for use in humans, Fontenot said.

The document looked “like something that was purchased on the Alibaba marketplace that was slid out the back doors of a Chinese chemical plant,” he said. So far, no compounding pharmacy has been fined or lost their license in Louisiana and Mississippi, according to state regulators. Al Carter, executive director of the National Association of Boards of Pharmacy, a nonprofit that represents state pharmacy regulators, said that it is not aware of any other states taking similar action.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NBCNews /  🏆 10. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Ozempic, Wegovy and all those crazy, vivid dreams: Is there a connection?Ozempic, Wegovy and all those crazy, vivid dreams: Is there a connection?Many people taking Ozempic for weight loss or Wegovy for diabetes management have reported vivid, intense dreams and nightmares as a side effect of the semaglutide medications.
Baca lebih lajut »

What’s behind shortages of Adderall, Ozempic and other meds?What’s behind shortages of Adderall, Ozempic and other meds?The University of Utah Drug Information Service says there were 301 active national drug shortages through this year’s first quarter.
Baca lebih lajut »

Why Is There Shortage of Adderall, Ozempic and Other Meds?Why Is There Shortage of Adderall, Ozempic and Other Meds?Shortages of drugs like Adderall are growing in the U.S., and experts see no clear path to resolving them. For patients, that can mean treatment delays, medication switches and other hassles filling a prescription. Here’s a deeper look at the issue.
Baca lebih lajut »

What's behind shortages of Adderall, Ozempic and other meds?What's behind shortages of Adderall, Ozempic and other meds?Drug shortages are growing in the United States, and experts see no clear path to resolving them. Here's a deeper look at the issue.
Baca lebih lajut »

What's behind shortages of Adderall, Ozempic and other meds?What's behind shortages of Adderall, Ozempic and other meds?Drug shortages are growing in the United States, and experts see no clear path to resolving them. Here's a deeper look at the issue.
Baca lebih lajut »

Adderall, Ozempic, other drug shortages have no clear resolution and could exist for years, experts sayAdderall, Ozempic, other drug shortages have no clear resolution and could exist for years, experts sayUnexpected manufacturing problems, demand spikes, and tightened ingredient supply lines have all contributed to the shortages, experts say.
Baca lebih lajut »



Render Time: 2025-02-28 07:21:20